Jacob M. van Laar

27.7k total citations · 1 hit paper
251 papers, 7.5k citations indexed

About

Jacob M. van Laar is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Jacob M. van Laar has authored 251 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Rheumatology, 106 papers in Pathology and Forensic Medicine and 74 papers in Immunology. Recurrent topics in Jacob M. van Laar's work include Systemic Sclerosis and Related Diseases (91 papers), Rheumatoid Arthritis Research and Therapies (85 papers) and Systemic Lupus Erythematosus Research (49 papers). Jacob M. van Laar is often cited by papers focused on Systemic Sclerosis and Related Diseases (91 papers), Rheumatoid Arthritis Research and Therapies (85 papers) and Systemic Lupus Erythematosus Research (49 papers). Jacob M. van Laar collaborates with scholars based in Netherlands, United Kingdom and Switzerland. Jacob M. van Laar's co-authors include Steven O’Reilly, Marzena Ciechomska, Thomas Hügle, Alan Tyndall, René E. M. Toes, Rachel Cant, T. Huizinga, Paco M J Welsing, Johannes W. G. Jacobs and René R. P. de Vries and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Blood.

In The Last Decade

Jacob M. van Laar

237 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology

2020 163 citations Jacob M. van Laar et al. profile →

Peers

Countries citing papers authored by Jacob M. van Laar

Since Specialization

Citations

This map shows the geographic impact of Jacob M. van Laar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob M. van Laar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob M. van Laar more than expected).

Fields of papers citing papers by Jacob M. van Laar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob M. van Laar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob M. van Laar. The network helps show where Jacob M. van Laar may publish in the future.

Co-authorship network of co-authors of Jacob M. van Laar

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob M. van Laar. A scholar is included among the top collaborators of Jacob M. van Laar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob M. van Laar. Jacob M. van Laar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Five years of the Digital Rheumatology Network: insights and future directions 2025 ·Antoni Chan, Johannes Knitza, Vincenzo Venerito, (unknown), Jutta Richter, Philip Hamann, Didier Hans, Martin Krusche, (unknown), Jacob M. van Laar, (unknown), Thomas Hügle	0
2	Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis 2024 ·BMJ Open ·(unknown), Gerty Schreibelt, (unknown), Paco M J Welsing, (unknown), (unknown), (unknown), Tjitske Duiveman‐de Boer, Willem van Eden, (unknown), I. Jolanda M. de Vries, Femke Broere, Jacob M. van Laar	4
3	The effects of lifestyle interventions on disease activity and quality of life in patients with systemic lupus erythematosus: A systematic review 2024 ·Autoimmunity Reviews ·(unknown), (unknown), (unknown), Julia Spierings, Jacob M. van Laar, (unknown)	3
4	Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation 2023 ·Journal of Scleroderma and Related Disorders ·(unknown), (unknown), Rick Admiraal, Anna van Rhenen, Stefan Nierkens, Jacob M. van Laar, Julia Spierings	1
5	Severe thrombotic microangiopathy after autologous stem cell transplantation in systemic sclerosis: a case report 2021 ·Lara D. Veeken ·(unknown), Helen L. Leavis, Pieter van Paassen, Anna van Rhenen, Sjoerd A.M.E.G. Timmermans, Evelien Ton, Jacob M. van Laar, Julia Spierings	3
6	Autologous stem-cell transplantation in systemic sclerosis-associated interstitial lung disease: early action in selected patients rather than escalation therapy for all 2021 ·Therapeutic Advances in Musculoskeletal Disease ·Julia Spierings, (unknown), Mareye Voortman, Jacob M. van Laar	8
7	AB0812 BIOMARKERS FOR CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE: A PILOT STUDY 2021 ·Annals of the Rheumatic Diseases ·(unknown), Mareye Voortman, Eveline M. Delemarre, Stefan Nierkens, Pim de Jong, (unknown), Jacob M. van Laar, Julia Spierings	1
8	Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis 2021 ·RMD Open ·Nadia M T Roodenrijs, Melinda Kedves, Attila Hamar, György Nagy, Jacob M. van Laar, Désirée van der Heijde, Paco M J Welsing	23
9	Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study 2021 ·Journal of Scleroderma and Related Disorders ·Julia Spierings, (unknown), (unknown), Jacob M. van Laar, Arwen H. Pieterse	1
10	Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis 2021 ·Lara D. Veeken ·Julia Spierings, Svetlana I. Nihtyanova, Emma Derrett‐Smith, Kristina E N Clark, Jacob M. van Laar, Voon H Ong, Christopher P. Denton	7
11	Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey 2020 ·RMD Open ·Rosaria Talarico, (unknown), Stefano Bombardieri, Gerd R Burmester, João Eurico Fonseca, Charissa Frank, Ilaria Galetti, É. Hachulla, Frédéric Houssiau, Ulf Müeller-Ladner, Matthias Schneider, Vanessa Smith, Giuseppe Turchetti, Jacob M. van Laar, Ana Vieira, Maurizio Cutolo, Marta Mosca	8
12	How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality? 2019 ·Lara D. Veeken ·Julia Spierings, C.H.M. van den Ende, (unknown), Hein J. Bernelot Moens, (unknown), Femke Bonte‐Mineur, (unknown), (unknown), (unknown), Jacob M. van Laar, Douwe J. Mulder, Judith Potjewijd, (unknown), (unknown), Anne A. Schouffoer, Alja J. Stel, (unknown), Alexandre E. Voskuyl, Jeska K de Vries‐Bouwstra, Madelon C Vonk, (unknown)	13
13	Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient’s perspective 2019 ·Lara D. Veeken ·Julia Spierings, (unknown), (unknown), (unknown), Arwen H. Pieterse, Madelon C Vonk, Alexandre E. Voskuyl, Jeska K de Vries‐Bouwstra, Marijke C. Kars, Jacob M. van Laar	14
14	Optimal care for systemic sclerosis patients: recommendations from a patient-centered and multidisciplinary mixed-method study and working conference 2018 ·Clinical Rheumatology ·Julia Spierings, C.H.M. van den Ende, (unknown), (unknown), Hein J. Bernelot Moens, Jacob M. van Laar, Jeska de Vries‐Bouwstra, Madelon C Vonk	18
15	Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey 2018 ·Annals of the Rheumatic Diseases ·Nadia M T Roodenrijs, Maria J. H. de Hair, Marlies C. van der Goes, Johannes W. G. Jacobs, Paco M J Welsing, Désirée van der Heijde, Daniel Aletaha, Maxime Dougados, Kimme L Hyrich, Iain B. McInnes, Ulf Müeller-Ladner, Ladislav Šenolt, Zoltán Szekanecz, Jacob M. van Laar, György Nagy	90
16	OP0310 Pregnancy outcome in women with systemic lupus erythematosus, a multicenter cohort-study 2017 ·Annals of the Rheumatic Diseases ·(unknown), Carolien N. H. Abheiden, (unknown), Jacob M. van Laar, R. H. W. M. Derksen, (unknown), Alexandre E. Voskuyl, A. Titia Lely, Marjon A. de Boer, Jip de Vries, Ruth Fritsch‐Stork	1
17	Building a Tailored, Patient-Guided, Web-Based Self-Management Intervention ‘ReumaUitgedaagd!’ for Adults With a Rheumatic Disease: Results of a Usability Study and Design for a Randomized Control Trail 2016 ·JMIR Research Protocols ·(unknown), (unknown), (unknown), (unknown), Aike A. Kruize, Jacob M. van Laar, Harmieke van Os‐Medendorp, Rinie Geenen	9
18	Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions in Acute Phase Markers and Inflammatory Markers S100A8 and A9 (Calgranulin A and B) 2012 ·Data Archiving and Networked Services (DANS) ·(unknown), Stephan Bek, (unknown), Arndt Brachat, J. Sieper, Paul Emery, Jürgen Braun, D. van der Heijde, Iain B. McInnes, Jacob M. van Laar, Robert Landewé, P Wordsworth, J. Wollenhaupt, (unknown), (unknown), (unknown), A. Wright, (unknown)	2
19	Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis 2007 ·Annals of the Rheumatic Diseases ·Madelon C Vonk, Zora Marjanovic, F.H.J. van den Hoogen, Sarah Zohar, A Schattenberg, WE Fibbe, (unknown), Éliane Gluckman, Frank Preijers, Arie P.J. van Dijk, J. J. Bax, P. Roblot, P. L. C. M. van Riel, Jacob M. van Laar, Dominique Farge	122
20	Autologous stem cell transplantation in rheumatoid arthritis 2001 ·eCite Digital Repository (University of Tasmania) ·John A. Snowden, John J. Moore, (unknown), Paul Cannell, Jacob M. van Laar, Sarah Bingham, Richard K. Burt, P. Emery, (unknown), (unknown), RM Lowenthal, Patrick Durez, A Tyndall	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact